Canada Biomarker Testing Services Market Size & Outlook
Related Markets
Canada biomarker testing services market highlights
- The Canada biomarker testing services market generated a revenue of USD 30.3 million in 2024 and is expected to reach USD 45.1 million by 2030.
- The Canada market is expected to grow at a CAGR of 7% from 2025 to 2030.
- In terms of segment, oncology was the largest revenue generating services in 2024.
- Oncology is the most lucrative services segment registering the fastest growth during the forecast period.
Biomarker testing services market data book summary
| Market revenue in 2024 | USD 30.3 million |
| Market revenue in 2030 | USD 45.1 million |
| Growth rate | 7% (CAGR from 2025 to 2030) |
| Largest segment | Oncology |
| Fastest growing segment | Oncology |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug discovery & development, Oncology |
| Key market players worldwide | Eurofins Scientific SE, SGS AG, Charles River Laboratories International Inc, Labcorp Drug Development, Thermo Fisher Scientific Inc, Icon PLC, IQVIA Holdings Inc, Syneos Health, Intertek Group PLC, BioAgilytix Labs |
Other key industry trends
- In terms of revenue, Canada accounted for 4.7% of the global biomarker testing services market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. biomarker testing services market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 433.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biomarker Testing Services Market Scope
Biomarker Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioAgilytix Labs | View profile | 501-1000 | Durham, North Carolina, United States, North America | http://www.bioagilytix.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| SGS AG | View profile | 103193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | https://www.sgs.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Canada biomarker testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biomarker testing services market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 52.48% in 2024. Horizon Databook has segmented the Canada biomarker testing services market based on drug discovery & development, oncology covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is considered a favorable location for biomarker testing services owing to the high potential for R&D activities. In addition, there is a growing need for developing new & innovative therapies.
Besides, growing R&D expenditure, increasing product approval, and a surge in investment for comprehensive biomarker testing to evaluate these drug candidates' safety, efficacy, and pharmacokinetics are expected to drive the market.
For instance, in March 2024, QuidelOrtho Corporation mentioned receiving approval in Canada from Health Canada for a Triage PLGF test for laboratory use. It is a fluorescence immunoassay for the Triage MeterPro Instrument that quantitatively determines the placental growth factor in the plasma of maternal specimens.
Reasons to subscribe to Canada biomarker testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada biomarker testing services market databook
-
Our clientele includes a mix of biomarker testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada biomarker testing services market , including forecasts for subscribers. This country databook contains high-level insights into Canada biomarker testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada biomarker testing services market size, by services, 2018-2030 (US$M)
Canada Biomarker Testing Services Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
